Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oncomodulin is a small, acidic calcium-binding protein of the parvalbumin family that promotes nerve regeneration, particularly after injury. It is expressed by macrophages during inflammation and in specific tissues like the retina, inner ear, and placenta. Its regenerative effects are mediated through the ArmC10 receptor and are enhanced by elevated intracellular cAMP levels. Oncomodulin differs structurally and functionally from other parvalbumins, exhibiting unique calcium-binding properties and conformational changes.
Oncomodulin binds to ArmC10 receptor, promoting axon regeneration post-injury. Requires elevated intracellular cAMP levels for enhanced activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oncomodulin (OCM).